<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39066223</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Exploring the Complexities of Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1060</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16071060</ELocationID><Abstract><AbstractText>Since the emergence of the SARS-CoV-2 virus in 2019, nearly 700 million COVID-19 cases and 7 million deaths have been reported globally. Despite most individuals recovering within four weeks, the Center for Disease Control (CDC) estimates that 7.5% to 41% develop post-acute infection syndrome (PAIS), known as 'Long COVID'. This review provides current statistics on Long COVID's prevalence, explores hypotheses concerning epidemiological factors, such as age, gender, comorbidities, initial COVID-19 severity, and vaccine interactions, and delves into potential mechanisms, including immune responses, viral persistence, and gut dysbiosis. Moreover, we conclude that women, advanced age, comorbidities, non-vaccination, and low socioeconomic status all appear to be risk factors. The reasons for these differences are still not fully understood and likely involve a complex relationship between social, genetic, hormonal, and other factors. Furthermore, individuals with Long COVID-19 seem more likely to endure economic hardship due to persistent symptoms. In summary, our findings further illustrate the multifaceted nature of Long COVID and underscore the importance of understanding the epidemiological factors and potential mechanisms needed to develop effective therapeutic strategies and interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Donald</LastName><ForeName>Jackson</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Graduate Studies, California Northstate University, 9700 West Taron Drive, Elk Grove, CA 95757, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilasy</LastName><ForeName>Shymaa E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-4967-583X</Identifier><AffiliationInfo><Affiliation>College of Dental Medicine, California Northstate University, 9700 West Taron Drive, Elk Grove, CA 95757, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Graduate Studies, California Northstate University, 9700 West Taron Drive, Elk Grove, CA 95757, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Shamy</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Graduate Studies, California Northstate University, 9700 West Taron Drive, Elk Grove, CA 95757, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">post COVID-19 condition</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>28</Day><Hour>14</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39066223</ArticleId><ArticleId IdType="pmc">PMC11281588</ArticleId><ArticleId IdType="doi">10.3390/v16071060</ArticleId><ArticleId IdType="pii">v16071060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sadeghi Dousari A., Taati Moghadam M., Satarzadeh N. COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease. Infect. Drug Resist. 2020;13:2819&#x2013;2828. doi: 10.2147/IDR.S259279.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S259279</ArticleId><ArticleId IdType="pmc">PMC7429403</ArticleId><ArticleId IdType="pubmed">32848431</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakusheva O., van den Broek-Altenburg E., Brekke G., Atherly A. Lives saved and lost in the first six month of the US COVID-19 pandemic: A retrospective cost-benefit analysis. PLoS ONE. 2022;17:e0261759. doi: 10.1371/journal.pone.0261759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261759</ArticleId><ArticleId IdType="pmc">PMC8782469</ArticleId><ArticleId IdType="pubmed">35061722</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long COVID. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F. Persistent Symptoms in Patients after Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford N.D., Slaughter D., Edwards D., Dalton A., Perrine C., Vahratian A., Saydah S. Long COVID and Significant Activity Limitation Among Adults, by Age&#x2014;United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb. Mortal. Wkly. Rep. 2023;72:866&#x2013;870. doi: 10.15585/mmwr.mm7232a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikanth S., Boulos J.R., Dover T., Boccuto L., Dean D. Identification and diagnosis of long COVID-19: A scoping review. Prog. Biophys. Mol. Biol. 2023;182:1&#x2013;7. doi: 10.1016/j.pbiomolbio.2023.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2023.04.008</ArticleId><ArticleId IdType="pmc">PMC10176974</ArticleId><ArticleId IdType="pubmed">37182545</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow A., Gray S.R., Bayes H.K., Sykes R., McGarry E., Anderson D., Boiskin D., Burke C., Cleland J.G.F., Goodyear C., et al. Prevention and early treatment of the long-term physical effects of COVID-19 in adults: Design of a randomised controlled trial of resistance exercise-CISCO-21. Trials. 2022;23:660. doi: 10.1186/s13063-022-06632-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-022-06632-y</ArticleId><ArticleId IdType="pmc">PMC9376905</ArticleId><ArticleId IdType="pubmed">35971155</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker K.K., Whooley O., Madden E.F., Ahrend E.E., Greene R.N. The long tail of COVID and the tale of long COVID: Diagnostic construction and the management of ignorance. Sociol. Health Illn. 2024;46((Suppl. S1)):189&#x2013;207. doi: 10.1111/1467-9566.13599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1467-9566.13599</ArticleId><ArticleId IdType="pmc">PMC9880676</ArticleId><ArticleId IdType="pubmed">36580406</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., O&#x2019;Hara M.E., Akrami A., Perego E., Olliaro P., Needham D.M. Long COVID: Aiming for a consensus. Lancet Respir. Med. 2022;10:632&#x2013;634. doi: 10.1016/S2213-2600(22)00135-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00135-7</ArticleId><ArticleId IdType="pmc">PMC9067938</ArticleId><ArticleId IdType="pubmed">35525253</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad P., Barker K.K. The social construction of illness: Key insights and policy implications. J. Health Soc. Behav. 2010;51((Suppl. S1)):S67&#x2013;S79. doi: 10.1177/0022146510383495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022146510383495</ArticleId><ArticleId IdType="pubmed">20943584</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A., McCorkell L., Nadkarni G.N., Parthasarathy S., Singh U., et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Markus K., Andersen K.M., Rudolph A.E., McGrath L.J., Nguyen J.L., Kyaw M.H., Whittle I., Blazos V., Heron L., et al. Definition and measurement of post-COVID-19 conditions in real-world practice: A global systematic literature review. BMJ Open. 2024;14:e077886. doi: 10.1136/bmjopen-2023-077886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-077886</ArticleId><ArticleId IdType="pmc">PMC10806676</ArticleId><ArticleId IdType="pubmed">38233057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie C.E., Lowe D.J., McAuley A., Mills N.L., Winter A.J., Black C., Scott J.T., O&#x2019;Donnell C.A., Blane D.N., Browne S., et al. True prevalence of long-COVID in a nationwide, population cohort study. Nat. Commun. 2023;14:7892. doi: 10.1038/s41467-023-43661-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-43661-w</ArticleId><ArticleId IdType="pmc">PMC10689486</ArticleId><ArticleId IdType="pubmed">38036541</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosworth M., Pawelek P., Ayoubkhani D. Prevalence of Ongoing Symptoms following Coronavirus (COVID-19) Infection in the UK: 2 February 2023.  [(accessed on 10 April 2024)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023.</Citation></Reference><Reference><Citation>National Center for Health Statistics  U.S. Census Bureau, H.P.S. 2022&#x2013;2023. Long COVID.  [(accessed on 14 January 2024)]; Available online:  https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm.</Citation></Reference><Reference><Citation>Pela G., Goldoni M., Solinas E., Cavalli C., Tagliaferri S., Ranzieri S., Frizzelli A., Marchi L., Mori P.A., Majori M., et al. Sex-Related Differences in Long-COVID-19 Syndrome. J. Womens Health. 2022;31:620&#x2013;630. doi: 10.1089/jwh.2021.0411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2021.0411</ArticleId><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Van der Feltz-Cornelis C.M., Holdsworth L., Hart S.P., O&#x2019;Halloran J., Holding S., Crooks M.G. Examining the relationship between inflammatory biomarkers during COVID-19 hospitalization and subsequent long-COVID symptoms: A longitudinal and retrospective study. Immun. Inflamm. Dis. 2023;11:e1052. doi: 10.1002/iid3.1052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.1052</ArticleId><ArticleId IdType="pmc">PMC10614127</ArticleId><ArticleId IdType="pubmed">37904690</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of Ongoing Symptoms following Coronavirus (COVID-19) Infection in the UK: 30 March 2023.  [(accessed on 10 April 2024)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023.</Citation></Reference><Reference><Citation>Tran V.T., Porcher R., Pane I., Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat. Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Pertynska-Marczewska M., Pertynski T. Premenopausal and postmenopausal women during the COVID-19 pandemic. Prz. Menopauzalny. 2022;21:200&#x2013;206. doi: 10.5114/pm.2022.118695.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pm.2022.118695</ArticleId><ArticleId IdType="pmc">PMC9551364</ArticleId><ArticleId IdType="pubmed">36254124</ArticleId></ArticleIdList></Reference><Reference><Citation>Teilmann S.C., Clement C.A., Thorup J., Byskov A.G., Christensen S.T. Expression and localization of the progesterone receptor in mouse and human reproductive organs. J. Endocrinol. 2006;191:525&#x2013;535. doi: 10.1677/joe.1.06565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/joe.1.06565</ArticleId><ArticleId IdType="pubmed">17170211</ArticleId></ArticleIdList></Reference><Reference><Citation>Phiel K.L., Henderson R.A., Adelman S.J., Elloso M.M. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol. Lett. 2005;97:107&#x2013;113. doi: 10.1016/j.imlet.2004.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2004.10.007</ArticleId><ArticleId IdType="pubmed">15626482</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007;28:521&#x2013;574. doi: 10.1210/er.2007-0001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2007-0001</ArticleId><ArticleId IdType="pubmed">17640948</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedotcheva T.A., Fedotcheva N.I., Shimanovsky N.L. Progesterone as an Anti-Inflammatory Drug and Immunomodulator: New Aspects in Hormonal Regulation of the Inflammation. Biomolecules. 2022;12:1299. doi: 10.3390/biom12091299.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12091299</ArticleId><ArticleId IdType="pmc">PMC9496164</ArticleId><ArticleId IdType="pubmed">36139138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghandehari S., Matusov Y., Pepkowitz S., Stein D., Kaderi T., Narayanan D., Hwang J., Chang S., Goodman R., Ghandehari H., et al. Progesterone in Addition to Standard of Care vs. Standard of Care Alone in the Treatment of Men Hospitalized with Moderate to Severe COVID-19: A Randomized, Controlled Pilot Trial. Chest. 2021;160:74&#x2013;84. doi: 10.1016/j.chest.2021.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.02.024</ArticleId><ArticleId IdType="pmc">PMC7896492</ArticleId><ArticleId IdType="pubmed">33621601</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramontana F., Battisti S., Napoli N., Strollo R. Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones. Front. Endocrinol. 2021;12:726696. doi: 10.3389/fendo.2021.726696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.726696</ArticleId><ArticleId IdType="pmc">PMC8675353</ArticleId><ArticleId IdType="pubmed">34925228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalidhindi R.S.R., Borkar N.A., Ambhore N.S., Pabelick C.M., Prakash Y.S., Sathish V. Sex steroids skew ACE2 expression in human airway: A contributing factor to sex differences in COVID-19? Am. J. Physiol. Lung Cell. Mol. Physiol. 2020;319:L843&#x2013;L847. doi: 10.1152/ajplung.00391.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00391.2020</ArticleId><ArticleId IdType="pmc">PMC7789973</ArticleId><ArticleId IdType="pubmed">32996784</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O., Merino E., Alfayate R., Torregrosa M.E., Andres M., Leon-Ramirez J.M., Boix V., Gil J., Pico A. Male pituitary-gonadal axis dysfunction in post-acute COVID-19 syndrome-Prevalence and associated factors: A Mediterranean case series. Clin. Endocrinol. 2022;96:353&#x2013;362. doi: 10.1111/cen.14537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14537</ArticleId><ArticleId IdType="pmc">PMC8444731</ArticleId><ArticleId IdType="pubmed">34160836</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen H., Klein S.L. Sex Differences in Immunity to Viral Infections. Front. Immunol. 2021;12:720952. doi: 10.3389/fimmu.2021.720952.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.720952</ArticleId><ArticleId IdType="pmc">PMC8438138</ArticleId><ArticleId IdType="pubmed">34531867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma C., Bayry J. High risk of autoimmune diseases after COVID-19. Nat. Rev. Rheumatol. 2023;19:399&#x2013;400. doi: 10.1038/s41584-023-00964-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-023-00964-y</ArticleId><ArticleId IdType="pmc">PMC10096101</ArticleId><ArticleId IdType="pubmed">37046064</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J.R., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Lott N., Gebhard C.E., Bengs S., Haider A., Kuster G.M., Regitz-Zagrosek V., Gebhard C. Sex hormones in SARS-CoV-2 susceptibility: Key players or confounders? Nat. Rev. Endocrinol. 2023;19:217&#x2013;231. doi: 10.1038/s41574-022-00780-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00780-6</ArticleId><ArticleId IdType="pmc">PMC9734735</ArticleId><ArticleId IdType="pubmed">36494595</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T., Ellingson M.K., Wong P., Israelow B., Lucas C., Klein J., Silva J., Mao T., Oh J.E., Tokuyama M., et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315&#x2013;320. doi: 10.1038/s41586-020-2700-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Burno A.M., Zang C., Xu Z., Wang F., Weiner M.G., Guthe N., Fitzgerald M., Kaushal R., Carton T.W., Metz T.D. Association between acquiring SARS-CoV-2 during pregnancy and post-acute sequelae of SARS-CoV-2 infection: RECOVER electronic health record cohort analysis. Lancet. 2024;24:73. doi: 10.1016/j.eclinm.2024.102654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2024.102654</ArticleId><ArticleId IdType="pmc">PMC11137338</ArticleId><ArticleId IdType="pubmed">38828129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated with Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadeh F.H., Wilson D.R., Agrawal D.K. Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies. Arch. Microbiol. Immunol. 2023;7:36&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10310313</ArticleId><ArticleId IdType="pubmed">37388279</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.B., Zeng N., Yuan K., Tian S.S., Yang Y.B., Gao N., Chen X., Zhang A.Y., Kondratiuk A.L., Shi P.P., et al. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. J. Infect. Public Health. 2023;16:660&#x2013;672. doi: 10.1016/j.jiph.2023.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.03.005</ArticleId><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Gross R.S., Mohandas S., Stein C.R., Case A., Dreyer B., Pajor N.M., Bunnell H.T., Warburton D., Berg E., et al. Postacute Sequelae of SARS-CoV-2 in Children. Pediatrics. 2024;153:e2023062570. doi: 10.1542/peds.2023-062570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-062570</ArticleId><ArticleId IdType="pmc">PMC10904902</ArticleId><ArticleId IdType="pubmed">38321938</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita-Rohwerder N., Beckmann L., Zens Y., Verma A. Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: A systematic review and meta-analysis. BMJ Evid. Based Med. 2022;27:274&#x2013;287. doi: 10.1136/bmjebm-2021-111828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2021-111828</ArticleId><ArticleId IdType="pmc">PMC8783973</ArticleId><ArticleId IdType="pubmed">35042748</ArticleId></ArticleIdList></Reference><Reference><Citation>Khafaja S., Youssef N., El Zein Z., Boutros C.F., Bou Karroum S., Abdel-Halim N., Salameh R., Hodroj D., El Meski N., Nasrallah O., et al. Multisystem inflammatory syndrome in children (MIS-C) and &#x201c;Near MIS-C&#x201d;: A continuum? Front. Pediatr. 2022;10:988706. doi: 10.3389/fped.2022.988706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.988706</ArticleId><ArticleId IdType="pmc">PMC9849890</ArticleId><ArticleId IdType="pubmed">36683795</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell V., Hall Dykgraaf S., Kidd M., Goodyear-Smith F. Long COVID and older people. Lancet Healthy Longev. 2022;3:e849&#x2013;e854. doi: 10.1016/S2666-7568(22)00245-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(22)00245-8</ArticleId><ArticleId IdType="pubmed">36480981</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller L., Di Benedetto S. From aging to long COVID: Exploring the convergence of immunosenescence, inflammaging, and autoimmunity. Front. Immunol. 2023;14:1298004. doi: 10.3389/fimmu.2023.1298004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1298004</ArticleId><ArticleId IdType="pmc">PMC10628127</ArticleId><ArticleId IdType="pubmed">37942323</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 2021;12:6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabnam S., Razieh C., Dambha-Miller H., Yates T., Gillies C., Chudasama Y.V., Pareek M., Banerjee A., Kawachi I., Lacey B., et al. Socioeconomic inequalities of Long COVID: A retrospective population-based cohort study in the United Kingdom. J. R. Soc. Med. 2023;116:263&#x2013;273. doi: 10.1177/01410768231168377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231168377</ArticleId><ArticleId IdType="pmc">PMC10469969</ArticleId><ArticleId IdType="pubmed">37164035</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill-Briggs F., Adler N.E., Berkowitz S.A., Chin M.H., Gary-Webb T.L., Navas-Acien A., Thornton P.L., Haire-Joshu D. Social Determinants of Health and Diabetes: A Scientific Review. Diabetes Care. 2020;44:258&#x2013;279. doi: 10.2337/dci20-0053.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dci20-0053</ArticleId><ArticleId IdType="pmc">PMC7783927</ArticleId><ArticleId IdType="pubmed">33139407</ArticleId></ArticleIdList></Reference><Reference><Citation>Descatha A., Evanoff B.A., Fadel M. Post-COVID condition or &#x201c;long COVID&#x201d;, return-to work, and occupational health research. Scand. J. Work Environ. Health. 2023;49:165&#x2013;169. doi: 10.5271/sjweh.4088.</Citation><ArticleIdList><ArticleId IdType="doi">10.5271/sjweh.4088</ArticleId><ArticleId IdType="pmc">PMC10621897</ArticleId><ArticleId IdType="pubmed">36944213</ArticleId></ArticleIdList></Reference><Reference><Citation>Hair N.L., Urban C. Association of Severe COVID-19 and Persistent COVID-19 Symptoms with Economic Hardship among US Families. JAMA Netw. Open. 2023;6:e2347318. doi: 10.1001/jamanetworkopen.2023.47318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.47318</ArticleId><ArticleId IdType="pmc">PMC10716716</ArticleId><ArticleId IdType="pubmed">38085541</ArticleId></ArticleIdList></Reference><Reference><Citation>Nusbaum N.J. Long COVID, Disability, and the Workplace. South. Med. J. 2023;116:718&#x2013;720. doi: 10.14423/SMJ.0000000000001586.</Citation><ArticleIdList><ArticleId IdType="doi">10.14423/SMJ.0000000000001586</ArticleId><ArticleId IdType="pmc">PMC10417233</ArticleId><ArticleId IdType="pubmed">37536704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty C., Bhattacharya M., Dhama K. SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic. Vaccines. 2023;11:682. doi: 10.3390/vaccines11030682.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030682</ArticleId><ArticleId IdType="pmc">PMC10054865</ArticleId><ArticleId IdType="pubmed">36992266</ArticleId></ArticleIdList></Reference><Reference><Citation>MacCallum-Bridges C., Hirschtick J.L., Patel A., Orellana R.C., Elliott M.R., Fleischer N.L. The impact of COVID-19 vaccination prior to SARS-CoV-2 infection on prevalence of long COVID among a population-based probability sample of Michiganders, 2020&#x2013;2022. Ann. Epidemiol. 2024;92:17&#x2013;24. doi: 10.1016/j.annepidem.2024.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2024.02.007</ArticleId><ArticleId IdType="pubmed">38382771</ArticleId></ArticleIdList></Reference><Reference><Citation>Puhach O., Adea K., Hulo N., Sattonnet P., Genecand C., Iten A., Jacquerioz F., Kaiser L., Vetter P., Eckerle I., et al. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat. Med. 2022;28:1491&#x2013;1500. doi: 10.1038/s41591-022-01816-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01816-0</ArticleId><ArticleId IdType="pubmed">35395151</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg-Morris L., Leach S., Xu Y., Martikainen J., Santosa A., Gisslen M., Li H., Nyberg F., Bygdell M. COVID-19 vaccine effectiveness against post-COVID-19 condition among 589,722 individuals in Sweden: Population based cohort study. BMJ. 2023;383:e076990. doi: 10.1136/bmj-2023-076990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2023-076990</ArticleId><ArticleId IdType="pmc">PMC10666099</ArticleId><ArticleId IdType="pubmed">37993131</ArticleId></ArticleIdList></Reference><Reference><Citation>Catala M., Mercade-Besora N., Kolde R., Trinh N.T.H., Roel E., Burn E., Rathod-Mistry T., Kostka K., Man W.Y., Delmestri A., et al. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: Staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir. Med. 2024;12:225&#x2013;236. doi: 10.1016/S2213-2600(23)00414-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00414-9</ArticleId><ArticleId IdType="pubmed">38219763</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B.A., Lim E.Y., Metaxaki M., Jackson S., Mactavous L., BioResource N., Lyons P.A., Doffinger R., Bradley J.R., Smith K.G.C., et al. Spontaneous, persistent, T cell-dependent IFN-gamma release in patients who progress to Long COVID. Sci. Adv. 2024;10:eadi9379. doi: 10.1126/sciadv.adi9379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adi9379</ArticleId><ArticleId IdType="pmc">PMC10881041</ArticleId><ArticleId IdType="pubmed">38381822</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlini V., Noonan D.M., Abdalalem E., Goletti D., Sansone C., Calabrone L., Albini A. The multifaceted nature of IL-10: Regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front. Immunol. 2023;14:1161067. doi: 10.3389/fimmu.2023.1161067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1161067</ArticleId><ArticleId IdType="pmc">PMC10287165</ArticleId><ArticleId IdType="pubmed">37359549</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1beta, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., Devason A.S., Umana I.C., Cox T.O., Dohnalova L., Litichevskiy L., Perla J., Lundgren P., Etwebi Z., Izzo L.T., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867.e20. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B., RECOVER Mechanistic Pathways Task Force Viral persistence, reactivation, and mechanisms of long COVID. eLife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafari M., Hall M., Golubchik T., Ayoubkhani D., House T., MacIntyre-Cockett G., Fryer H.R., Thomson L., Nurtay A., Kemp S.A., et al. Prevalence of persistent SARS-CoV-2 in a large community surveillance study. Nature. 2024;626:1094&#x2013;1101. doi: 10.1038/s41586-024-07029-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-024-07029-4</ArticleId><ArticleId IdType="pmc">PMC10901734</ArticleId><ArticleId IdType="pubmed">38383783</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman M.A., Mallah S.I., Khalid W., Ryan Moran L., Abousedu Y.A.I., Jassim G.A. Characteristics of Patients with SARS-CoV-2 Positive Cerebrospinal Fluid: A Systematic Review. Int. J. Gen. Med. 2021;14:10385&#x2013;10395. doi: 10.2147/IJGM.S333966.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S333966</ArticleId><ArticleId IdType="pmc">PMC8721017</ArticleId><ArticleId IdType="pubmed">35002295</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.S., Lee H., Lee S.W., Kwon R., Rhee S.Y., Lee J.A., Koyanagi A., Smith L., Fond G., Boyer L., et al. Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19: A Binational Cohort Study. Ann. Intern. Med. 2024;177:291&#x2013;302. doi: 10.7326/M23-1831.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M23-1831</ArticleId><ArticleId IdType="pubmed">38437702</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., Saidara E., Maes M. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID. Viruses. 2023;15:400. doi: 10.3390/v15020400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020400</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J.E., Okyay R.A., Licht W.E., Hurley D.J. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10:763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss A.B., Greene C., Dayaramani C., Rauchman S.H., Stecker M.M., De Leon J., Pinkhasov A. Long COVID, the Brain, Nerves, and Cognitive Function. Neurol. Int. 2023;15:821&#x2013;841. doi: 10.3390/neurolint15030052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15030052</ArticleId><ArticleId IdType="pmc">PMC10366776</ArticleId><ArticleId IdType="pubmed">37489358</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou S.H., Beghi E., Helbok R., Moro E., Sampson J., Altamirano V., Mainali S., Bassetti C., Suarez J.I., McNett M., et al. Global Incidence of Neurological Manifestations Among Patients Hospitalized with COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw. Open. 2021;4:e2112131. doi: 10.1001/jamanetworkopen.2021.12131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Wang S. The immune mechanism of the nasal epithelium in COVID-19-related olfactory dysfunction. Front. Immunol. 2023;14:1045009. doi: 10.3389/fimmu.2023.1045009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1045009</ArticleId><ArticleId IdType="pmc">PMC10387544</ArticleId><ArticleId IdType="pubmed">37529051</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik J.R., Acharya A., Avedissian S.N., Byrareddy S.N., Fletcher C.V., Podany A.T., Dyavar S.R. ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics. Int. J. Mol. Sci. 2023;24:8622. doi: 10.3390/ijms24108622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24108622</ArticleId><ArticleId IdType="pmc">PMC10218482</ArticleId><ArticleId IdType="pubmed">37239978</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta C.S., Torices S., da Rosa B.G., Marcos A.C., Alvarez-Rosa L., Siqueira M., Moreno-Rodriguez T., Matos A.d.R., Caetano B.C., Martins J.S.C.d.C., et al. Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-kappaB Non-Canonical Pathway and Mitochondrial Remodeling. Viruses. 2023;15:745. doi: 10.3390/v15030745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030745</ArticleId><ArticleId IdType="pmc">PMC10056985</ArticleId><ArticleId IdType="pubmed">36992454</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F., Goereci Y., Franke C., Silling S., Bosl F., Maier F., Heger E., Deiman B., Pruss H., Onur O.A., et al. Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection. Ann. Neurol. 2022;91:150&#x2013;157. doi: 10.1002/ana.26262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26262</ArticleId><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A., Lu P., Geraghty A.C., Song E., Lee M.H., Wood J., O&#x2019;Dea M.R., Dutton S., Shamardani K., Nwangwu K., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e16. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Blevins H.M., Xu Y., Biby S., Zhang S. The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Front. Aging Neurosci. 2022;14:879021. doi: 10.3389/fnagi.2022.879021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.879021</ArticleId><ArticleId IdType="pmc">PMC9226403</ArticleId><ArticleId IdType="pubmed">35754962</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha A.B., Mehta A., Pokharel P., Mishra A., Adhikari L., Shrestha S., Yadav R.S., Khanal S., Sah R., Nowrouzi-Kia B., et al. Long COVID Syndrome and Cardiovascular Manifestations: A Systematic Review and Meta-Analysis. Diagnostics. 2023;13:491. doi: 10.3390/diagnostics13030491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13030491</ArticleId><ArticleId IdType="pmc">PMC9913936</ArticleId><ArticleId IdType="pubmed">36766599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad K.O., Lin A., Rodriguez J.B.C. Cardiac Manifestations of Post-Acute COVID-19 Infection. Curr. Cardiol. Rep. 2022;24:1775&#x2013;1783. doi: 10.1007/s11886-022-01793-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-022-01793-3</ArticleId><ArticleId IdType="pmc">PMC9628458</ArticleId><ArticleId IdType="pubmed">36322364</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing C., Gluckman T.J., Bhave N.M., Allen L.A., Chung E.H., Spatz E.S., Ammirati E., Baggish A.L., Bozkurt B., Cornwell W.K., 3rd, et al. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 2022;79:1717&#x2013;1756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyongyosi M., Alcaide P., Asselbergs F.W., Brundel B., Camici G.G., Martins P.D.C., Ferdinandy P., Fontana M., Girao H., Gnecchi M., et al. Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: A joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc. Res. 2023;119:336&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I., Schulze A., Evers G., Harmening K., Vink H., Kumpers P., Mohr M., Rovas A. Persistent capillary rarefication in long COVID syndrome. Angiogenesis. 2023;26:53&#x2013;61. doi: 10.1007/s10456-022-09850-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Querfeld U., Mak R.H., Pries A.R. Microvascular disease in chronic kidney disease: The base of the iceberg in cardiovascular comorbidity. Clin. Sci. 2020;134:1333&#x2013;1356. doi: 10.1042/CS20200279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200279</ArticleId><ArticleId IdType="pmc">PMC7298155</ArticleId><ArticleId IdType="pubmed">32542397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Sahu S.K., Cano M., Kuppuswamy V., Bajwa J., McPhatter J., Pine A., Meizlish M.L., Goshua G., Chang C.H., et al. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci. Immunol. 2021;6:eabh2259. doi: 10.1126/sciimmunol.abh2259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh2259</ArticleId><ArticleId IdType="pmc">PMC8158979</ArticleId><ArticleId IdType="pubmed">34446527</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Rhermoul F.Z., Fedorowski A., Eardley P., Taraborrelli P., Panagopoulos D., Sutton R., Lim P.B., Dani M. Autoimmunity in Long COVID and POTS. Oxf. Open Immunol. 2023;4:iqad002. doi: 10.1093/oxfimm/iqad002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqad002</ArticleId><ArticleId IdType="pmc">PMC10224806</ArticleId><ArticleId IdType="pubmed">37255928</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques K.C., Quaresma J.A.S., Falcao L.F.M. Cardiovascular autonomic dysfunction in &#x201c;Long COVID&#x201d;: Pathophysiology, heart rate variability, and inflammatory markers. Front. Cardiovasc. Med. 2023;10:1256512. doi: 10.3389/fcvm.2023.1256512.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1256512</ArticleId><ArticleId IdType="pmc">PMC10502909</ArticleId><ArticleId IdType="pubmed">37719983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston C.K., Swiatkiewicz I., Taub P.R. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19:1880&#x2013;1889. doi: 10.1016/j.hrthm.2022.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pmc">PMC9287587</ArticleId><ArticleId IdType="pubmed">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley M.C., Gallagher C., Ong E., Langdon A., Chieng J., Bailey D., Page A., Lim H.S., Lau D.H. High Incidence of Autonomic Dysfunction and Postural Orthostatic Tachycardia Syndrome in Patients with Long COVID: Implications for Management and Health Care Planning. Am. J. Med. 2023 doi: 10.1016/j.amjmed.2023.06.010. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.06.010</ArticleId><ArticleId IdType="pmc">PMC10307671</ArticleId><ArticleId IdType="pubmed">37391116</ArticleId></ArticleIdList></Reference><Reference><Citation>Daines L., Zheng B., Pfeffer P., Hurst J.R., Sheikh A. A clinical review of long-COVID with a focus on the respiratory system. Curr. Opin. Pulm. Med. 2022;28:174&#x2013;179. doi: 10.1097/MCP.0000000000000863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCP.0000000000000863</ArticleId><ArticleId IdType="pmc">PMC7612723</ArticleId><ArticleId IdType="pubmed">35131989</ArticleId></ArticleIdList></Reference><Reference><Citation>She Y.X., Yu Q.Y., Tang X.X. Role of interleukins in the pathogenesis of pulmonary fibrosis. Cell Death Discov. 2021;7:52. doi: 10.1038/s41420-021-00437-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00437-9</ArticleId><ArticleId IdType="pmc">PMC7960958</ArticleId><ArticleId IdType="pubmed">33723241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Zhang L., Wei R., Dai W., Zeng R., Luo D., Jiang R., Zhuo Z., Yang Q., Li J., et al. Risks of digestive diseases in long COVID: Evidence from a population-based cohort study. BMC Med. 2024;22:14. doi: 10.1186/s12916-023-03236-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03236-4</ArticleId><ArticleId IdType="pmc">PMC10777515</ArticleId><ArticleId IdType="pubmed">38195495</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Kuang D., Li D., Yang J., Yan J., Xia Y., Zhang F., Cao H. Roles of the gut microbiota in severe SARS-CoV-2 infection. Cytokine Growth Factor. Rev. 2022;63:98&#x2013;107. doi: 10.1016/j.cytogfr.2022.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2022.01.007</ArticleId><ArticleId IdType="pmc">PMC8802135</ArticleId><ArticleId IdType="pubmed">35131164</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira G.L.V., Oliveira C.N.S., Pinzan C.F., de Salis L.V.V., Cardoso C.R.B. Microbiota Modulation of the Gut-Lung Axis in COVID-19. Front. Immunol. 2021;12:635471. doi: 10.3389/fimmu.2021.635471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.635471</ArticleId><ArticleId IdType="pmc">PMC7945592</ArticleId><ArticleId IdType="pubmed">33717181</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer A.M., Matos Y.L., Lin H.C., Ryman S.G., Birg A., Quinn D.K., Parada A.N., Vakhtin A.A. Gut-brain pathogenesis of post-acute COVID-19 neurocognitive symptoms. Front. Neurosci. 2023;17:1232480. doi: 10.3389/fnins.2023.1232480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1232480</ArticleId><ArticleId IdType="pmc">PMC10568482</ArticleId><ArticleId IdType="pubmed">37841680</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy M.W. Paxlovid as a potential treatment for long COVID. Expert. Opin. Pharmacother. 2023;24:1839&#x2013;1843. doi: 10.1080/14656566.2023.2262387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2023.2262387</ArticleId><ArticleId IdType="pubmed">37731377</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman K.O. RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms (RECOVER-VITAL)  [(accessed on 22 June 2024)]; Available online:  https://clinicaltrials.gov/study/NCT05965726.</Citation></Reference><Reference><Citation>Durstenfeld M.S., Peluso M.J., Lin F., Peyser N.D., Isasi C., Carton T.W., Henrich T.J., Deeks S.G., Olgin J.E., Pletcher M.J., et al. Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study. J. Med. Virol. 2024;96:e29333. doi: 10.1002/jmv.29333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29333</ArticleId><ArticleId IdType="pmc">PMC10786003</ArticleId><ArticleId IdType="pubmed">38175151</ArticleId></ArticleIdList></Reference><Reference><Citation>Congdon S., Narrowe Z., Yone N., Gunn J., Deng Y., Nori P., Cowman K., Islam M., Rikin S., Starrels J. Nirmatrelvir/ritonavir and risk of long COVID symptoms: A retrospective cohort study. Sci. Rep. 2023;13:19688. doi: 10.1038/s41598-023-46912-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-46912-4</ArticleId><ArticleId IdType="pmc">PMC10640584</ArticleId><ArticleId IdType="pubmed">37951998</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante C.T., Buse J.B., Liebovitz D.M., Nicklas J.M., Puskarich M.A., Cohen K., Belani H.K., Anderson B.J., Huling J.D., Tignanelli C.J., et al. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): A multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect. Dis. 2023;23:1119&#x2013;1129. doi: 10.1016/S1473-3099(23)00299-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00299-2</ArticleId><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>Isman A., Nyquist A., Strecker B., Harinath G., Lee V., Zhang X., Zalzala S. Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19. Brain Behav. Immun. Health. 2024;36:100733. doi: 10.1016/j.bbih.2024.100733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2024.100733</ArticleId><ArticleId IdType="pmc">PMC10862402</ArticleId><ArticleId IdType="pubmed">38352659</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker C.E., Nguyen T.M., Segal D., MacDonald J.K., Chande N. Low dose naltrexone for induction of remission in Crohn&#x2019;s disease. Cochrane Database Syst. Rev. 2018;4:CD010410. doi: 10.1002/14651858.CD010410.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010410.pub3</ArticleId><ArticleId IdType="pmc">PMC6494424</ArticleId><ArticleId IdType="pubmed">29607497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultani G., Samsudeen A.F., Osborne B., Turner N. NAD(+): A key metabolic regulator with great therapeutic potential. J. Neuroendocrinol. 2017;29:e12508. doi: 10.1111/jne.12508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jne.12508</ArticleId><ArticleId IdType="pubmed">28718934</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau R.I., Su Q., Lau I.S.F., Ching J.Y.L., Wong M.C.S., Lau L.H.S., Tun H.M., Mok C.K.P., Chau S.W.H., Tse Y.K., et al. A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): A randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis. 2024;24:256&#x2013;265. doi: 10.1016/S1473-3099(23)00685-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00685-0</ArticleId><ArticleId IdType="pubmed">38071990</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>